Tagged biomarker-detection

Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab
Press Release

Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab

LungOI Is Among The First AI-based Tests To Receive a Medicare Payment Rate.

 Read More
Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration With Sectra
Press Release

Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration With Sectra

ImageneOI is the first NSCLC genomic profiling AI tool on the Sectra Amplifier Marketplace.

 Read More
Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling
Press Release

Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling

Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study.

 Read More
Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care
Press Release

Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care

Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence.

 Read More
Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
Press Release

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

 Read More
Press Release

Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to Its Scientific Advisory Board

Visionaries and Experts, Each Having Played a Historical Role in Advancing Precision Oncology Into Current Clinical Practice

 Read More
Imagene's AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
Press Release

Imagene's AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation

A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients

 Read More
Imagene Wins Frost & Sullivan's Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis
Press Release

Imagene Wins Frost & Sullivan's Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis

 Read More
Imagene Named 'Oncology Innovation of the Year' at 2022 BioTech Breakthrough Awards
Press Release

Imagene Named 'Oncology Innovation of the Year' at 2022 BioTech Breakthrough Awards

Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry

 Read More
New AI Tech Can Detect Cancerous Biomarkers in Real-Time Research
Press Release

New AI Tech Can Detect Cancerous Biomarkers in Real-Time Research

The research done by Imagene and Sheba Medical Center was recently published in 'Modern Pathology' journal.

 Read More
Imagene and Sourasky Medical Center to Present Collaborative Research: Image-Based Identification of HER2 Status in H&E-Stained Breast Cancer Slides
Press Release

Imagene and Sourasky Medical Center to Present Collaborative Research: Image-Based Identification of HER2 Status in H&E-Stained Breast Cancer Slides

The research will be presented at the European Congress of Pathology (ECP) 2022

 Read More